TCF7 and neoplasm: Analysis using the X50 T cell panel revealed that progressors had significantly higher frequencies of circulating TCF1+ CD8+ and TCF1+ CD4+ T cells (P < 0.05) than responders (Fig. 4 B), which contrasts with our findings in the tumor tissue.